3 AI Stocks Caught in the Crossfire of the Iran War, and What Smart Investors Should Do in 2026

Operation Epic Fury (launched Feb. 28) and subsequent airstrikes have disrupted key maritime routes (Strait of Hormuz), affecting ~20% of global oil trade and pushing crude prices higher, adding inflationary and macro risk. Palantir generated $1.9B in U.S. government revenue in 2025 (+55% YoY), its shares are up ~12% since the campaign began, and an analyst projects a potential additional ~40% upside if the conflict endures. Nvidia faces near-term supply-chain exposure via foundry reliance (e.g., TSMC) and higher fuel/materials costs but remains strategically positioned for defense AI and sovereign-AI projects; CrowdStrike benefits from elevated cyberthreat activity (e.g., Z‑Pentest) strengthening demand for AI-driven endpoint security. The article recommends long-term buy-and-hold exposure to PLTR, NVDA and CRWD while flagging heightened volatility and market uncertainty.

Analysis

Winners are likely to be vendors that can convert short-term geopolitical urgency into multi-year contracted revenue streams: platform players with sticky telemetry and SOC integrations (high retention SaaS) will see faster budget approvals, while pure-play foundries exposed to chokepoints will suffer margin compression as customers accelerate geographic diversification. A 3–12 month spike in insurance and rerouting costs will mechanically raise landed costs for hyperscalers and hyperscale GPU buyers, creating a window where vertically integrated incumbents that can localize supply capture incremental orders and pricing power.

Key risks are bifurcated by time horizon. In the next days–weeks, shipping disruption and insurance-cost repricing are the principal drivers of realized impact; a sustained conflict over 3–12 months raises the probability of hard export controls or forced onshoring of AI hardware that could remove portions of addressable market from global suppliers. Over 12–36 months, budget pass-through and sovereign AI buildouts create durable demand but also invite political procurement risk and programmatic audits that can slow revenue recognition and re-rating.

The consensus is underweight the distinction between “defense-adjacent” revenue and truly captureable commercial demand. Palantir and CrowdStrike are being discussed as binary defense winners, but Palantir faces contract timing and oversight risk while CrowdStrike benefits from high gross retention and low marginal cost of telemetry expansion — meaning CRWD’s earnings leverage is more immediate and less binary. Conversely, the market may be underpricing the foundry reallocation tail: a 3–6 month disruption that lowers TSM throughput even 5–10% would disproportionately benefit rival capacity holders and equipment vendors able to onboard volumes quickly.

Key Decisions for Investors

• Buy PLTR 12-month call options (or a 3% NAV outright equity position if options are unavailable). Rationale: asymmetric upside from defense re-rating over 9–12 months; target +35–45% upside. Risk: premium paid / equity drawdown; size 2–3% NAV and set a -20% stop on stock positions to protect against contract-timing disappointment.
• Long CRWD stock on any >3% intraday pullback or buy 9–12 month calls for leveraged exposure. Rationale: cyber budget acceleration is immediate with high retention and low incremental CAC; target +20–30% in 6–12 months. Risk: enterprise procurement cycles; position size 2–3% NAV and buy a 6–9% protective put if adding >4% NAV.
• Pair trade — go long NVDA / short TSM at equal notional for a 3–9 month horizon. Rationale: NVDA captures long-term AI compute demand while TSM is most exposed to near-term routing/insurance and customer reshoring; this expresses hardware demand vs chokepoint execution risk. Risk/Reward: if supply normalizes NVDA could rally 25–40% vs TSM lagging 10–20%; cap exposure to 3–4% NAV each leg and tighten if divergence >15%.
• Buy a TSM 3–6 month put spread to hedge sector tail risk (limited premium). Rationale: priced downside protection if chokepoints or insurance shocks translate into measurable throughput losses. Risk: limited to paid premium; reward if TSM shares reprice downward by >10% within the spread tenor.